首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Transplant immunology

缩写:TRANSPL IMMUNOL

ISSN:0966-3274

e-ISSN:1878-5492

IF/分区:1.4/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1501
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Panagiotis G Asteris,Amir H Gandomi,Danial J Armaghani et al. Panagiotis G Asteris et al.
Background: Allogeneic hematopoietic stem transplantation (allo-HSCT) constitutes a curative treatment for various hematological malignancies. However, various complications limit the therapeutic efficacy of this approach...
Xue Li,Wei Wang,Jing Jiang et al. Xue Li et al.
JC virus-associated nephropathy (JCV PyVAN) is a late infectious complication after kidney transplantation and represents a rare cause of allograft dysfunction. Herein, we report a case of JCV PyVAN in a 34-year-old woman presenting with el...
Satona Tanaka,Naoki Tanimine,Akiyoshi Nakakura et al. Satona Tanaka et al.
Background: The characteristics and prognostic impacts of early graft infiltration after lung transplantation and clinically diagnosed acute rejection remain unclear. Furthermore, the alloimmune response status in lung tr...
Kerry A Swanson,Hannah M Phelps,Matthew T Grant et al. Kerry A Swanson et al.
In utero hematopoietic cell transplantation (IUHCT) exploits tolerogenic fetal immunologic development to facilitate engraftment of donor. Non-hematopoietic donor-derived cells have been described in both in-utero and post-natal models of h...
Steven D Heron,Jim Shaw,Johannes Dapprich Steven D Heron
Chronic rejection remains an obstacle to long-term allograft survival. Donor-specific anti-HLA antibodies (DSA) play a significant role in causing chronic antibody-mediated allograft rejection. Exposure to mismatched HLA antigens via transf...
Emmanuel Aydin-Ghormoz,Jorge Ortiz,Kathryn Schubauer et al. Emmanuel Aydin-Ghormoz et al.
Objectives: In the US, 92 % of kidney transplant recipients are treated with induction therapy. This analysis assesses the impact of induction immunosuppression on outcomes such as graft failure, patient mortality, and le...
Mohammad Hassan Sohouli,Arefeh Zahmatkesh,Zahid Khan et al. Mohammad Hassan Sohouli et al.
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) provides children with life-threatening conditions an opportunity for survival. Complications from graft-versus-host disease (GVHD) are a major source ...
Keven Vachon,Marc-Antoine Tardif,Étienne Paillé et al. Keven Vachon et al.
Background: Thymoglobulin® (ATG), a rabbit anti-human thymocyte globulin, is used in allogeneic hematopoietic stem cell transplantation (HSCT) mainly to prevent the development of graft-versus-host disease (GVHD). Three ...
Alexandra Plavsa,Tara Suresh,Stuti Dalal et al. Alexandra Plavsa et al.
Background: Alemtuzumab-containing conditioning regimens are used for allogeneic hematopoietic stem cell transplantation (HSCT) to reduce acute and chronic graft-versus-host disease (GVHD) and the risk of graft rejection....
Alejandra Nuñez-Venzor,Asya Zubillaga-Mares,Aczel I Sánchez-Cedillo et al. Alejandra Nuñez-Venzor et al.
Background: Liver transplantation is the treatment of choice in patients with chronic liver disease and acute liver failure of any etiology. Scales such as the Survival Outcome Following Transplantation (SOFT) score and t...